Life Biosciences LLC

Overview

• HeadquartersDE¹
• Legal formLimited Liability Company

See how the biggest companies compare on our leaderboards

Corporate structure

Life Biosciences LLC sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (1 companies). Each entity in the chart links to its source.

Leadership

Named in SEC Form D filings

People the company listed in its private-offering notices.

• Executive OfficerAmit Shashank named Apr 24, 2026²
• Executive Officer, DirectorGerald McLaughlin named Apr 24, 2026²
• Executive OfficerMichael Ringel named Apr 24, 2026²
• Executive OfficerSharon Rosenzweig-Lipson named Apr 24, 2026²
• DirectorDavid Guyer named Apr 24, 2026²
• DirectorDavid Sinclair named Apr 24, 2026²
• DirectorIlan Stern named Apr 24, 2026²
• DirectorStuart Gibson named Apr 24, 2026²

Filings

1 filings to the SEC since October 2021: 1 private raises. The latest 1:

1. Apr 24, 2026D EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Life Biosciences LLC has told the SEC it owns more than 5% of 1 company, latest first (Schedules 13D and 13G).

• ALTERITY THERAPEUTICS LTDSC 13D/A Mar 4, 2022 to Oct 31, 2022³

Funding

Where the company's money came from, by calendar year: private offerings filed with the SEC, federal grants, loans, contracts and other assistance from USAspending.gov, and PPP loans from the SBA. Each bar links to the records below.

Private raises

Private offerings the company reported to the SEC on Form D. The amount is what the latest filing says was sold so far, charted in the year of the first sale. Covers filings since Oct 1, 2021.

1. Nov 25, 2025Raised $31 million in a private offering of equity² Form D: 8 investors so far Form D